BlackRock Fund Advisors’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$99.2M Buy
2,326,240
+293,926
+14% +$12.5M 0.02% 1200
2016
Q3
$96.4M Buy
2,032,314
+119,553
+6% +$5.97M 0.02% 1099
2016
Q2
$96.6M Buy
1,912,761
+23,831
+1% +$1.2M 0.02% 1005
2016
Q1
$91.3M Sell
1,888,930
-17,884
-0.9% -$690K 0.02% 1031
2015
Q4
$75M Buy
1,906,814
+81,058
+4% +$3.24M 0.02% 1189
2015
Q3
$69.3M Sell
1,825,756
-136,188
-7% -$5.74M 0.02% 1203
2015
Q2
$77.9M Sell
1,961,944
-35,884
-2% -$1.12M 0.02% 1198
2015
Q1
$53.5M Buy
1,997,828
+138,275
+7% +$3.9M 0.01% 1469
2014
Q4
$54.6M Buy
1,859,553
+121,090
+7% +$2.99M 0.01% 1404
2014
Q3
$35.1M Sell
1,738,463
-31,457
-2% -$607K 0.01% 1586
2014
Q2
$29.6M Sell
1,769,920
-175,672
-9% -$2.49M 0.01% 1773
2014
Q1
$29M Buy
1,945,592
+18,735
+1% +$288K 0.01% 1787
2013
Q4
$28.2M Buy
1,926,857
+61,003
+3% +$982K 0.01% 1782
2013
Q3
$32.1M Buy
1,865,854
+173,793
+10% +$2.58M 0.01% 1651
2013
Q2
$19.6M Buy
+1,692,061
New +$19.4M 0.01% 1871

Other funds holding AMED

BlackRock Fund Advisors's AMED Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Amedisys (AMED) stake by 14% in Q4 2016, buying an estimated $12.5M and bringing the position to 2,326,240 shares worth $99.2M. The position accounts for 0.02% of the portfolio, ranked #1200.

BlackRock Fund Advisors first reported a position in AMED in Q2 2013 and has held it in 15 quarters since. 159 funds tracked by Wall St. Rank hold AMED as of Q4 2016.

  • BlackRock Fund Advisors held 2,326,240 shares of Amedisys worth $99.2M as of Q4 2016.
  • BlackRock Fund Advisors bought 293,926 Amedisys shares in Q4 2016, an estimated $12.5M.
  • Amedisys made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1200 holding.
  • BlackRock Fund Advisors first reported a position in Amedisys in Q2 2013 and has held it in 15 quarters since.
  • 159 funds tracked by Wall St. Rank held Amedisys as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.